SRPT SAREPTA THERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 26 analyst firms say about SAREPTA THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
26 rated views · 27 analyst/firm records · 26 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 805
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8010
Recent analyst activity · last 90 days
Our tracked history has 13 reports on SRPT from 12 analyst firms in the last 90 days (27 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged and 6 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Brian P Skorney | Hold | 1 Sep 2026 | 20.00 USD |
| Barclays | Eliana Merle | Hold | 22 Jun 2026 | 20.00 USD |
| Barclays | Gena Wang | Hold | 28 Jan 2026 | 20.00 USD |
| Benchmark | Unnamed analyst | Sell | 9 Sep 2026 | — |
| Cantor Fitzgerald | Kristen Kluska | Hold | 6 Aug 2026 | 21.00 USD |
| Citigroup | Yigal Nochomovitz | Sell | 26 Mar 2026 | 13.00 USD |
| Deutsche Bank | Unnamed analyst | Sell | 26 Mar 2026 | 14.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Hold | 10 Aug 2026 | 19.00 USD |
| Freedom Capital Markets | Ilya Zubkov | Buy | 4 Mar 2026 | 25.00 USD |
| Goldman Sachs | Salveen Richter | Hold | 25 Jun 2026 | 18.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 10 Mar 2026 | 19.00 USD |
| H.C. Wainwright | Mitchell S. Kapoor | Sell | 5 Oct 2026 | 5.00 USD |
| Jefferies | Andrew Tsai | Buy | 3 Mar 2026 | 30.00 USD |
| JPMorgan | Anupam Rama | Hold | 30 Sep 2026 | 20.00 USD |
| Leerink Partners | Joseph P Schwartz | Hold | 17 Sep 2026 | 20.00 USD |
| Mizuho | Uy Ear | Buy | 12 Mar 2026 | 31.00 USD |
| Needham | Gil Blum | Sell | 28 Sep 2026 | — |
| Oppenheimer | Kostas Biliouris | Buy | 19 Mar 2026 | 37.00 USD |
| Piper Sandler | Biren Amin | Hold | 18 Oct 2026 | 20.00 USD |
| RBC Capital Markets | Brian Abrahams | Hold | 8 Oct 2026 | 17.00 USD |
| TD Cowen | Ritu S Baral | Hold | 15 Jun 2026 | 17.00 USD |
| Wedbush | Yun Zhong | Buy | 6 Aug 2026 | 35.00 USD |
| Weiss Ratings | Unnamed analyst | — | 28 Oct 2026 | — |
| Wells Fargo | Yanan Zhu | Buy | 6 Aug 2026 | 38.00 USD |
| William Blair | Lachlan Hanbury-Brown | Hold | 23 Sep 2026 | — |
| Wolfe Research | Andy Chen | Buy | 9 Jul 2026 | 27.00 USD |
| Data feed RESEARCH | Research Team | Sell | 5 Oct 2026 | 15.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:56 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.